美國居民不適用 XM 服務。
S
S

Stryker

技術摘要

指標價值趨勢
指標價值趨勢
指標價值趨勢
指標S3S2S1PR1R2R3

財經新聞

Masimo prepared to provide one board seat if activist Politan drops proxy contest

UPDATE 4-Masimo prepared to provide one board seat if activist Politan drops proxy contest Adds Politan's response in paragraph 4, 6, 8 and 9 By Christy Santhosh and Pratik Jain May 9 (Reuters) - Masimo MASI.O said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee and drops its proxy contest.
A
S

Baxter raises annual profit forecast on strong demand for medical devices

REFILE-Baxter raises annual profit forecast on strong demand for medical devices Corrects to add story keyword used by media customers May 2 (Reuters) - Medical device maker Baxter International BAX.N raised its annual profit forecast and beat quarterly estimates on Thursday, banking on strong demand for its infusion pumps and dialysis products. Investor expectations around the performance of medical device makers have been heightened since last November due to higher demand for procedures, espe
A
S

Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices

Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices May 2 (Reuters) - Medtech firm Zimmer Biomet Holdings ZBH.N beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer's results extend a strong quarter for medical device makers, including peer Stryker Corp SYK.N which raised its annual profit outlook betting on steady demand for its hip and knee implant
S
Z

Teleflex beats quarterly profit estimates on healthy demand for medical devices

Teleflex beats quarterly profit estimates on healthy demand for medical devices May 2 (Reuters) - Teleflex TFX.N reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices. The Wayne, Pennsylvania-based company also raised the lower end of its 2024 adjusted profit forecast to $13.60 from $13.55 per share, keeping the upper end at $13.95 per share.
S
T

Stryker lifts 2024 profit forecast on strong demand for medical devices, implants

REFILE-Stryker lifts 2024 profit forecast on strong demand for medical devices, implants Adds media packaging code April 30 (Reuters) - Stryker Corp SYK.N lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be between $11.85 and $12.05, raised from the previous range of between $11.70 and $12. The analysts' average estimate for 2024 is pegged at $11.85 per share.
S

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明